BeStock  
Stocks › Biotechnology › DSGN

Design Therapeutics DSGN

US equityMarket cap rank #3510Biotechnology
$9.02 −$0.30 (-3.22%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $9.02 0.00%
Open$9.33
Prev close$9.32
Day range$8.96 – $9.57
Volume281.9K
Market cap$577.61M
P/E (TTM)–
Dividend yield–

Price chart

Daily bars for up to one year, weekly bars for the 5-year view. Averages are 50/200 trading days (10/40 weeks on the 5-year view). Triangles mark past earnings reports, colored by that day’s move; ticks mark ex-dividend dates — hover either for the date. Volume is the shaded bars under the price; switch on RSI or MACD above for a full-history oscillator panel, or Bollinger Bands for the same 20-day/2-standard-deviation channel used in the Technical signals table.

DSGN at a glance

DSGN is priced at $9.02 right now, down 3.22% on the session. That puts its market value at $577.61M, 3510th largest among the 3753 stocks we cover.

It is close to the bottom of its 52-week range ($8.21 to $17.25), 47.7% under the high. Holders are ahead 8.0% over twelve months, but down 40.8% across the last three months.

On the chart it has slipped under both the 50-day ($11.14) and 200-day ($12.17) moving averages; RSI is 33, and the last 30 sessions moved at roughly 69% annualized volatility.

Revenue for the quarter ended Sep 2026 was $0.00, and a net loss of $20.29M.

3 analysts follow the stock and the average call is "buy". The mean target, $21.67, sits 140.2% over where the stock trades.

This summary is put together from the numbers on the page and updates when they do. It describes the data; it is not a forecast or a recommendation.

Key statistics

Bid / Ask$3.62 / $14.44
Average price today$9.09
Volume281.9KAvg (90d) 531.2K
Turnover$2.56M
Turnover rate0.94%of shares outstanding
Volume ratio0.99vs. recent average pace
Day amplitude6.55%
Market cap$577.61M
Float market cap$270.41M
Shares outstanding29.98M
EPS (TTM)-$1.22
P/B2.86
Book value / share$3.16
Net profit (TTM)-$78.12M
Net assets$202.23M
30-day volatility68.5%annualized
Avg daily range (ATR)6.95%of price, 14 days
Max drawdown (1y)-43.4%-43.4% from 1y peak

Quote as of Nov 20, 2026 8:10 pm ET. Prices can lag the live tape. This is background information, not a recommendation.

BeStock Grade

C
BeStock Grade

Composite of 3 factors below, ranked against the 3734 U.S. stocks BeStock covers.

C
Valuation

Cheaper than usual on its own 5-year P/E history scores higher.

F
Momentum

Trading closer to its 52-week high than most peers scores higher.

B
Wall Street

3 analysts, consensus Buy.

How this is scored: each factor above is a 0–100 percentile rank against every other stock BeStock covers (or, for Wall Street, against the five-point Strong Buy–Sell scale). The overall grade is the plain average of whichever factors apply to this stock — no factor is weighted more than another. That average maps to a letter: A ≥ 85, B ≥ 70, C ≥ 50, D ≥ 30, otherwise F. Recomputed from the data on this page as prices and filings update — it describes where a stock ranks today, not a forecast, and not a BeStock recommendation to buy or sell.

Six-factor research snapshot

Overall percentile: 43.7 · 2026-11-22 14:27 UTC. Higher values indicate a stronger relative ranking.

FactorPercentile
Valuation—
Growth—
Profitability5.9
Momentum23.4
Financial health99.5
Analyst view94.1

Price forecast

What Wall Street analysts and Morningstar's fair-value model expect for the stock

Analyst price target (avg)$21.67+140.2% vs. current price
Consensus ratingBuy3 analysts covering
Morningstar fair value$17.68Price is below fair value

Wall Street’s average 12-month target is $21.67, 140.2% above today’s price, with a consensus rating of Buy. Morningstar’s fair value model puts the stock at $17.68, so shares trade 49.0% below that estimate. On earnings multiple, it sits in the 35th percentile of its own five-year valuation range (cheaper than usual).

Figures are Wall Street analyst consensus and Morningstar’s independent fair-value model, sourced as noted above.

Performance

Price return over each window, from adjusted daily and weekly closes

1 day
-3.2%
1 week
-13.8%
1 month
-14.0%
3 months
-40.8%
6 months
-17.8%
Year to date
-3.8%
1 year
+8.0%
Day range
$8.96$9.57
52-week range
$8.21$17.25

Technical signals

Full technicals →
Trend readStrong downtrend

0 bullish · 6 bearish of 7 signals

IndicatorValueSignal
Price vs 20-day average-12.3%Bearish
Price vs 50-day average-19.0%Bearish
Price vs 200-day average-25.9%Bearish
50-day vs 200-day50d below 200dBearish
RSI (14)32.8Bearish
MACD (12,26,9)-0.49Bearish
Bollinger band position-5%Neutral

Standard indicator readings worked out from daily closes. They describe how the price has behaved, not where it is going.

How DSGN ranks on BeStock

Market value#3492 of 3734
Closeness to 52-week high#2949 of 3724
Dollar volume today#2825 of 3734

Ranks are among the 3,734 or so U.S.-listed stocks BeStock covers, recalculated whenever prices refresh. A tile is left out when the measure does not apply, such as yield for a stock that pays no dividend.

DSGN is not currently one of the 10 holdings in BeStock Momentum, our rules-based momentum strategy.

Since 2020-12-28, the strategy has returned 401.7% (183.6% for the equal-weight average of BeStock’s coverage over the same stretch). Holdings can change any trading day, not just on a fixed schedule. Backtested performance, updated daily — not a guarantee of future results, and not a BeStock recommendation.

Strategy Backtest

Pick a strategy above and run the backtest to see its simulated performance on DSGN.

Rule-based technical strategies computed from this stock’s own price history only. Signals use only data available through the prior trading day (no look-ahead), and trading costs, slippage and taxes aren’t modeled. A backtested rule performing well in the past is not a guarantee of future results — this is an educational illustration, not investment advice.

Community Sentiment on DSGN

No votes yet — be the first to weigh in.

Reader sentiment, not investment advice. One vote per visitor; click again to change it.

DSGN stock: common questions

What is DSGN's latest share price?

$9.02 is the latest print for DSGN, a move of -3.22% against yesterday's close of $9.32. Today's low and high so far: $8.96 and $9.57.

How large is Design Therapeutics by market value?

Equity value comes to $577.61M at the current price. By that measure it is number 3510 of the 3753 names in our coverage.

Is DSGN near its 52-week high or low?

The year's floor is $8.21 and the ceiling $17.25. Shares are 47.7% away from that ceiling.

Does Design Therapeutics pay a dividend?

Our data shows no dividend paid by Design Therapeutics over the trailing twelve months.

Is DSGN rated a buy by Wall Street?

Of 3 analysts, 100% say buy, 0% hold and 0% sell. Price targets average $21.67, with the most cautious at $19.00 and the most optimistic at $26.00.

BeStock publishes market data and analysis for information only. Nothing here is investment advice or a solicitation to buy or sell any security, and none of it is tailored to your financial situation, goals, or risk tolerance. Quotes may be delayed and figures can contain errors; check primary sources before you trade. How we source and calculate these pages.

Discussion

No comments yet — be the first to weigh in on DSGN.

Sign in to join the discussion.

Scroll to Top